NEULAND LABORATORIES
|
The Current P/E Ratio of NEULAND LABORATORIES is 71.34.
Share Price | ₹14,496.3 | Jul 17,2025 |
Market Cap | ₹18,555.3 Cr | |
Earnings-TTM | ₹260.1 Cr | TTM-Consolidated Results |
Price/Earnings | 71.34x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of NEULAND LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹18,555.3 Cr] as on Jul 17,2025
(/) Earnings [ ₹260.1 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 71.34x ]
Thus, for NEULAND LABORATORIES , the investors are currently willing to pay 71.34 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of NEULAND LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of NEULAND LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of NEULAND LABORATORIES
PE Ratio Performance Analysis for NEULAND LABORATORIES
- NEULAND LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 30.88x.
- NEULAND LABORATORIES 's operated at median p/e ratio of 26.86x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, NEULAND LABORATORIES 's p/e ratio peaked in Mar2025 at 59.57x.
- NEULAND LABORATORIES 's p/e ratio hit its five-year low in Mar2023 of 14.12x.
How does NEULAND LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
NEULAND LABORATORIES | 260.11 | 71.34 | 18,555.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,980.10 | 37.22 | 408,667.0 |
DIVIS LABORATORIES LTD | 2,191.00 | 82.21 | 180,131.0 |
CIPLA LTD | 5,291.05 | 22.63 | 119,745.0 |
TORRENT PHARMACEUTICALS LTD | 1,911.00 | 62.06 | 118,603.0 |
DR REDDYS LABORATORIES LTD | 5,703.50 | 18.48 | 105,429.0 |
MANKIND PHARMA LTD | 2,003.22 | 54.40 | 108,985.0 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 21.41 | 98,812.2 |
LUPIN LTD | 3,306.26 | 27.01 | 89,310.1 |
AUROBINDO PHARMA LTD | 3,515.26 | 19.07 | 67,021.6 |
ABBOTT INDIA LTD | 1,414.44 | 51.27 | 72,520.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs NEULAND LABORATORIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.48x |
Max industry PE | 82.21x |
Median industry PE | 37.22x |
Average industry PE | 42.47x |
You may also like the below Video Courses